{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:35:38Z","timestamp":1788478538628,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11739-024-03803-4","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T16:03:12Z","timestamp":1730476992000},"page":"423-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Individuation of a cut-off value of triglyceride-glucose index for incident diabetes mellitus in patients with essential hypertension"],"prefix":"10.1007","volume":"20","author":[{"given":"Maria","family":"Perticone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermal","family":"Shehaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Suraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"3803_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12170-012-0283-8","volume":"7","author":"V Sales","year":"2013","unstructured":"Sales V, Patti ME (2013) The ups and downs of insulin resistance and type 2 diabetes: lessons from genomic analyses in humans. Curr Cardiovasc Risk Rep 7:46\u201359. https:\/\/doi.org\/10.1007\/s12170-012-0283-8","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"3803_CR2","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","volume":"373","author":"AG Tabak","year":"2009","unstructured":"Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of Type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215\u20132221. https:\/\/doi.org\/10.1016\/S0140-6736(09)60619-X","journal-title":"Lancet"},{"key":"3803_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.mcna.2004.04.013","volume":"88","author":"RA DeFronzo","year":"2004","unstructured":"DeFronzo RA (2004) Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88:787\u2013835. https:\/\/doi.org\/10.1016\/j.mcna.2004.04.013","journal-title":"Med Clin North Am"},{"issue":"Suppl 2","key":"3803_CR4","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1055\/s-2001-18576","volume":"109","author":"HE Lebovitz","year":"2001","unstructured":"Lebovitz HE (2001) Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 109(Suppl 2):S135\u2013S148. https:\/\/doi.org\/10.1055\/s-2001-18576","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"3803_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","volume":"96","author":"AH Berg","year":"2005","unstructured":"Berg AH, Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939\u2013949. https:\/\/doi.org\/10.1161\/01.RES.0000163635.62927.34","journal-title":"Circ Res"},{"key":"3803_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052036","volume":"7","author":"KB Gast","year":"2012","unstructured":"Gast KB, Tjeerdema N, Stijnen T, Smit JWA, Dekkers OM (2012) Insulin resistance and risk of incident cardiovascular events in adults without diabetes: metaanalysis. PLoS One 7:e52036. https:\/\/doi.org\/10.1371\/journal.pone.0052036","journal-title":"PLoS One"},{"key":"3803_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2023.02.006","volume":"154","author":"S Raghubeer","year":"2024","unstructured":"Raghubeer S (2024) The influence of epigenetics and inflammation on cardiometabolic risks. Semin Cell Dev Biol 154:175184. https:\/\/doi.org\/10.1016\/j.semcdb.2023.02.006","journal-title":"Semin Cell Dev Biol"},{"key":"3803_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A et al (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377:13\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1614362","journal-title":"N Engl J Med"},{"key":"3803_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s1098-3597(99)90002-9","volume":"2","author":"L Khaodhiar","year":"1999","unstructured":"Khaodhiar L, McCowen KC, Blackburn GL (1999) Obesity and its comorbid conditions. Clin Cornerstone 2:17\u201331. https:\/\/doi.org\/10.1016\/s1098-3597(99)90002-9","journal-title":"Clin Cornerstone"},{"key":"3803_CR10","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","volume":"366","author":"DW Haslam","year":"2005","unstructured":"Haslam DW, James WPT (2005) Obesity. Lancet 366:1197\u20131209. https:\/\/doi.org\/10.1016\/S0140-6736(05)67483-1","journal-title":"Lancet"},{"issue":"suppl 3","key":"3803_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2337\/diacare.16.3.56","volume":"16","author":"PZ Zimmet","year":"1993","unstructured":"Zimmet PZ (1993) Hyperinsulinemia. How innocent a bystander? Diabetes Care 16(suppl 3):55\u201370. https:\/\/doi.org\/10.2337\/diacare.16.3.56","journal-title":"Diabetes Care"},{"key":"3803_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/cvr\/cvx098","volume":"113","author":"B Icli","year":"2017","unstructured":"Icli B, Feinberg MW (2017) MicroRNAs in dysfunctional adipose tissue: cardiovascular implications. Cardiovasc Res 113:1024\u20131034. https:\/\/doi.org\/10.1093\/cvr\/cvx098","journal-title":"Cardiovasc Res"},{"key":"3803_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrcardio.2009.55","volume":"6","author":"PA Kern","year":"2009","unstructured":"Kern PA, Rocha VZ, Libby P (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6:399\u2013409. https:\/\/doi.org\/10.1038\/nrcardio.2009.55","journal-title":"Nat Rev Cardiol"},{"key":"3803_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12944-017-0562-y","volume":"16","author":"R Zheng","year":"2017","unstructured":"Zheng R, Mao Y (2017) Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis 16:175. https:\/\/doi.org\/10.1186\/s12944-017-0562-y","journal-title":"Lipids Health Dis"},{"key":"3803_CR15","doi-asserted-by":"publisher","unstructured":"Jin JL, Cao YX, Wu LG, You XD, Guo YL, Wu NQ, et al (2018) Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. J Thorac Dis 10:6137\u20136146. https:\/\/doi.org\/10.21037\/jtd.2018.10.79","DOI":"10.21037\/jtd.2018.10.79"},{"key":"3803_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12933-022-01541-5","volume":"21","author":"H Li","year":"2022","unstructured":"Li H, Zuo Y, Qian F, Chen S, Tian X, Wang P et al (2022) Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol 21:105. https:\/\/doi.org\/10.1186\/s12933-022-01541-5","journal-title":"Cardiovasc Diabetol"},{"key":"3803_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2014-000016","volume":"2","author":"G Sesti","year":"2014","unstructured":"Sesti G, Hribal ML, Fiorentino TV, Sciacqua A, Perticone F (2014) Elevated 1h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. BMJ Open Diabetes Res Care 2:e000016. https:\/\/doi.org\/10.1136\/bmjdrc-2014-000016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3803_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2016.11.020","volume":"256","author":"F Andreozzi","year":"2017","unstructured":"Andreozzi F, Mannino GC, Perticone M, Perticone F, Sesti G (2017) Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile. Atherosclerosis 256:15\u201320. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.020","journal-title":"Atherosclerosis"},{"key":"3803_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3096","volume":"35","author":"TV Fiorentino","year":"2019","unstructured":"Fiorentino TV, Succurro E, Andreozzi F, Sciacqua A, Perticone F, Sesti G (2019) One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovasculare diseases: cross-sectional data from the CATAMERI study. Diabetes Metab Res Rev 35:e3096. https:\/\/doi.org\/10.1002\/dmrr.3096","journal-title":"Diabetes Metab Res Rev"},{"issue":"7","key":"3803_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"3803_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299\u2013304. https:\/\/doi.org\/10.1089\/met.2008.0034","journal-title":"Metab Syndr Relat Disord"},{"issue":"5","key":"3803_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ijo.2017.14","volume":"41","author":"B Kang","year":"2017","unstructured":"Kang B, Yang Y, Lee EY, Yang HK, Kim HS, Lim SY et al (2017) Triglycerides\/glucose index is a useful surrogate marker of insulin resistance among adolescents. Int J Obes 41(5):789\u2013792. https:\/\/doi.org\/10.1038\/ijo.2017.14","journal-title":"Int J Obes"},{"issue":"6","key":"3803_CR23","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al (2007) 2007 Guidelines for the management of arterial hypertension. J Hypertens 25(6):1105\u20131187. https:\/\/doi.org\/10.1097\/HJH.0b013e3281fc975a","journal-title":"J Hypertens"},{"issue":"7","key":"3803_CR24","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01-hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Red\u00f3n J, Zanchetti A, B\u00f6hm M et al (2013) 2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of the arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281\u20131357. https:\/\/doi.org\/10.1097\/01-hjh.0000431740.32696.cc","journal-title":"J Hypertens"},{"key":"3803_CR25","doi-asserted-by":"publisher","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al (2018) 2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 36(10):1953\u20132041https:\/\/doi.org\/10.1097\/HJH.0000000000001940","DOI":"10.1097\/HJH.0000000000001940"},{"key":"3803_CR26","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595\u20131607. https:\/\/doi.org\/10.2337\/diab.37.12.1595","journal-title":"Diabetes"},{"key":"3803_CR27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/ATVBAHA.119.310961","volume":"39","author":"AM Schmidt","year":"2019","unstructured":"Schmidt AM (2019) Diabetes and cardiovascular disease. Arterioscler Thromb Vasc Biol 39:558\u2013568. https:\/\/doi.org\/10.1161\/ATVBAHA.119.310961","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3803_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2337\/diacare.14.3.173","volume":"14","author":"RA De Fronzo","year":"1991","unstructured":"De Fronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173\u2013194. https:\/\/doi.org\/10.2337\/diacare.14.3.173","journal-title":"Diabetes Care"},{"key":"3803_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ypmed.2016.01.022","volume":"86","author":"D Navarro-Gonz\u00e1lez","year":"2016","unstructured":"Navarro-Gonz\u00e1lez D, S\u00e1nchez-\u00cd\u00f1igo L, Pastrana-Delgado J, Fern\u00e1ndez-Montero A, Martinez JA (2016) Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort. Prev Med 86:99\u2013105. https:\/\/doi.org\/10.1016\/j.ypmed.2016.01.022","journal-title":"Prev Med"},{"key":"3803_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/ijerph20010787","volume":"20","author":"M Massimino","year":"2022","unstructured":"Massimino M, Monea G, Marinaro G, Rubino M, Mancuso E, Mannino GC, Andreozzi F (2022) The Triglycerides and Glucose (TyG) Index Is Associated with 1-Hour Glucose Levels during an OGTT. Int J Environ Res Public Health 20:787. https:\/\/doi.org\/10.3390\/ijerph20010787","journal-title":"Int J Environ Res Public Health"},{"key":"3803_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJMoa0904130","volume":"362","author":"PW Franks","year":"2010","unstructured":"Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC (2010) Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 362:485\u2013493. https:\/\/doi.org\/10.1056\/NEJMoa0904130","journal-title":"N Engl J Med"},{"key":"3803_CR32","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. Lancet 389:2239\u20132251. https:\/\/doi.org\/10.1016\/S0140-6736(17)30058-2","journal-title":"Lancet"},{"key":"3803_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","volume":"379","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Rawshani A, Franzen S, Sattar N, Eliasson B, Svensson AM et al (2018) Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 379:633\u2013644. https:\/\/doi.org\/10.1056\/NEJMoa1800256","journal-title":"N Engl J Med"},{"key":"3803_CR34","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/archinte.149.7.1514","volume":"149","author":"NM Kaplan","year":"1989","unstructured":"Kaplan NM (1989) The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridaemia, and hypertension. Arch lnt Med 149:1514\u20131520. https:\/\/doi.org\/10.1001\/archinte.149.7.1514","journal-title":"Arch lnt Med"},{"issue":"1","key":"3803_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1001\/jama.1967.03130140068008","volume":"202","author":"S Pell","year":"1967","unstructured":"Pell S, D\u2019Alonzo CA (1967) Some aspects of hypertension in diabetes mellitus. JAMA 202(1):104\u2013110","journal-title":"JAMA"},{"issue":"5","key":"3803_CR36","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/01.HYP.0000125726.92964.ab","volume":"43","author":"P Verdecchia","year":"2004","unstructured":"Verdecchia P, Reboldi G, Angeli F, Borgioni C, Gattobigio R, Filippucci L et al (2004) Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 43(5):963\u2013969. https:\/\/doi.org\/10.1161\/01.HYP.0000125726.92964.ab","journal-title":"Hypertension"},{"issue":"1","key":"3803_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/XCE.0000000000000114","volume":"6","author":"N Sunkara","year":"2017","unstructured":"Sunkara N, Ahsan CH (2017) Hypertension in diabetes and the risk of cardiovascular disease. Cardiovasc Endocrinol 6(1):33\u201338. https:\/\/doi.org\/10.1097\/XCE.0000000000000114","journal-title":"Cardiovasc Endocrinol"},{"key":"3803_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1056\/NEJM199602083340607","volume":"334","author":"GM Reaven","year":"1996","unstructured":"Reaven GM, Lithell H, Landsberg L (1996) Hypertension and associated metabolic abnormalities. The role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374\u2013381. https:\/\/doi.org\/10.1056\/NEJM199602083340607","journal-title":"N Engl J Med"},{"key":"3803_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijcard.2008.12.131","volume":"142","author":"F Perticone","year":"2010","unstructured":"Perticone F, Sciacqua A, Maio R, Perticone M, Galiano Leone G, Bruni R et al (2010) Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. Int J Cardiol 142:236\u2013241. https:\/\/doi.org\/10.1016\/j.ijcard.2008.12.131","journal-title":"Int J Cardiol"},{"key":"3803_CR40","doi-asserted-by":"publisher","first-page":"13804","DOI":"10.3390\/ijms131113804","volume":"13","author":"A Sciacqua","year":"2012","unstructured":"Sciacqua A, Grillo N, Quero M, Sesti G, Perticone F (2012) Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patients. Int J Mol Sci 13:13804\u201313815. https:\/\/doi.org\/10.3390\/ijms131113804","journal-title":"Int J Mol Sci"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03803-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T20:38:05Z","timestamp":1744144685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03803-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3803"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03803-4","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors have no competing interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The CATAMERI study was approved on October 17th, 2012 (approval number 2012.63) by the Ethics Committee of the Azienda Ospedaliero-Universitaria Mater Domini of Catanzaro (Italy). All the participants gave their informed written consent to study participation and all the investigations were made according with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}}]}}